Literature DB >> 2895682

Early damage of vascular endothelium during cardiac ischaemia.

W C Hülsmann1, M L Dubelaar.   

Abstract

To determine the site of reperfusion damage after ischaemia the leakage of xanthine dehydrogenase and xanthine oxidase was assessed in vascular and interstitial effluents. Contractile function was reduced during hypoperfusion but improved after the addition of superoxide dismutase and vasoxin to the perfusion medium. Both interstitial fluid and coronary effluent showed dehydrogenase and oxidase activity after no flow ischaemia. Furthermore, the ratio of lactate dehydrogenase to creatine kinase in coronary effluents was reduced. These findings indicate that the myocardial interstitium may be a site of ischaemic membrane damage since this space contains hypoxanthine and xanthine oxidase. The protective effect of superoxide dismustase also indicates the possibility of damage due to oxygen derived radicals in the cardiac interstitium during low flow perfusion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2895682     DOI: 10.1093/cvr/21.9.674

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  4 in total

1.  Biochemical profile of propionyl-L-carnitine.

Authors:  W C Hülsmann
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Release of fatty acid-binding protein and long chain fatty acids from isolated rat heart after ischemia and subsequent calcium paradox.

Authors:  M M Vork; J F Glatz; G J van der Vusse
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

3.  Carnitine requirement of vascular endothelial and smooth muscle cells in imminent ischemia.

Authors:  W C Hülsmann; M L Dubelaar
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

4.  Vulnerability of vascular endothelium in lipopolysaccharide toxicity: effect of (acyl) carnitine on endothelial stability.

Authors:  W C Hülsmann
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.